We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5471:TSEDaido Steel Co., Ltd. Analysis

Data as of 2026-06-17 - not real-time

NT$60.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Sonix Technology (5471.TW) is trading at TWD 60.5, comfortably above its 20‑day SMA (53.3), 50‑day SMA (48.1) and 200‑day SMA (39.4), confirming a strong bullish bias. The MACD line (2.21) sits above its signal (1.68) and the histogram is positive, reinforcing the upward momentum, while the RSI at 69.6 signals that the stock is approaching overbought territory. Technical support sits around TWD 46.1 and resistance near the 52‑week high of TWD 60.8, suggesting limited upside in the very short run. Volume is on an increasing trend, and the beta of 0.57 indicates lower systematic risk, yet the 30‑day volatility of 65% points to considerable price swings.
Fundamentally, the company posts a robust 23.9% revenue growth and a forward PE of 6.9, dramatically lower than the trailing PE of 85.2 and the industry average PE of 37.2, implying that future earnings are expected to improve sharply. However, the DCF‑derived fair value of TWD 29.3 is far below the current price, highlighting a significant overvaluation gap, and the dividend payout ratio of 140% raises doubts about dividend sustainability. In this context, the stock offers strong short‑term technical momentum but appears expensive relative to intrinsic estimates, with a modest dividend yield of 1.74% that may not be reliable.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI approaching overbought levels
  • Price near 52‑week high resistance
  • DCF fair value far below market price

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and rising volume
  • Strong revenue growth and low forward PE
  • Valuation gap and dividend sustainability concerns

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Sustained revenue growth trajectory
  • Low beta indicating defensive characteristics
  • Potential price correction aligning market price with intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth23.90%
Profit Margin5.77%
P/E Ratio85.2
ROE4.57%
ROA2.30%
P/B Ratio2.9
Op. Cash FlowNT$208.4M
Free Cash FlowNT$91.9M
Industry P/E37.2

Technical Analysis

TrendBullish
RSI69.6
SupportNT$46.10
ResistanceNT$60.80
MA 20NT$53.30
MA 50NT$48.08
MA 200NT$39.45
MACDBullish
VolumeIncreasing
Fear & Greed Index92.13

Valuation

Fair ValueNT$29.34
GradeOvervalued
TypeBlend
Dividend Yield1.74%

Risk Assessment

Beta0.57
Volatility65.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.